BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19144878)

  • 21. [Inducing collaterals in due time. Arteriogenesis as a preventive principle].
    Bondke A; Buschmann IR; Bode C; Buschmann EE
    Hamostaseologie; 2007 Dec; 27(5):363-72. PubMed ID: 18060248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of arteriogenesis.
    Cai W; Schaper W
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):681-92. PubMed ID: 18685784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of inflammatory cytokines on arteriogenesis.
    Buschmann I; Heil M; Jost M; Schaper W
    Microcirculation; 2003 Jun; 10(3-4):371-9. PubMed ID: 12851653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular therapeutic modalities for arterial obstructive syndromes.
    Staudacher DL; Preis M; Lewis BS; Grossman PM; Flugelman MY
    Pharmacol Ther; 2006 Jan; 109(1-2):263-73. PubMed ID: 16243400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The range of adaptation by collateral vessels after femoral artery occlusion.
    Eitenmüller I; Volger O; Kluge A; Troidl K; Barancik M; Cai WJ; Heil M; Pipp F; Fischer S; Horrevoets AJ; Schmitz-Rixen T; Schaper W
    Circ Res; 2006 Sep; 99(6):656-62. PubMed ID: 16931799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical review of clinical arteriogenesis research.
    van Royen N; Piek JJ; Schaper W; Fulton WF
    J Am Coll Cardiol; 2009 Dec; 55(1):17-25. PubMed ID: 20117358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytokine-eluting stents as new drug-delivery devices for angiogenic therapy].
    Grundmann S; Hoefer I; Bode C
    Hamostaseologie; 2008 Oct; 28(4):195-202. PubMed ID: 18836644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization].
    Kalka C; Asahara T; Krone W; Isner JM
    Herz; 2000 Sep; 25(6):611-22. PubMed ID: 11076319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary stenosis and mechanisms of collateral vessel growth].
    Iwakura A; Komeda M; Fujita M
    Nihon Rinsho; 1998 Oct; 56(10):2504-8. PubMed ID: 9796310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy.
    Annex BH; Simons M
    Cardiovasc Res; 2005 Feb; 65(3):649-55. PubMed ID: 15664391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision].
    Herold J; Said S; Braun-Dullaeus R
    Zentralbl Chir; 2014 Oct; 139(5):508-17. PubMed ID: 24089345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic arteriogenesis has arrived.
    Schaper W
    Circulation; 2001 Oct; 104(17):1994-5. PubMed ID: 11673333
    [No Abstract]   [Full Text] [Related]  

  • 37. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.
    van Royen N; Piek JJ; Legemate DA; Schaper W; Oskam J; Atasever B; Voskuil M; Ubbink D; Schirmer SH; Buschmann I; Bode C; Buschmann EE
    Vasc Med; 2003; 8(3):191-6. PubMed ID: 14989560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arteriogenic growth factors, chemokines and proteases as a prerequisite for arteriogenesis.
    Heil M; Schaper W
    Drug News Perspect; 2005 Jun; 18(5):317-22. PubMed ID: 16193104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
    Ylä-Herttuala S; Rissanen TT; Vajanto I; Hartikainen J
    J Am Coll Cardiol; 2007 Mar; 49(10):1015-26. PubMed ID: 17349880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology of the collateral circulation (arteriogenesis).
    Buschmann I; Schaper W
    J Pathol; 2000 Feb; 190(3):338-42. PubMed ID: 10685067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.